首页> 美国卫生研究院文献>Neuro-Oncology >GENE-39. UNANTICIPATED GERMLINE CANCER SUSCEPTIBILITY MUTATIONS IDENTIFIED DURING ROUTINE NEXT GENERATION SEQUENCING OF PRIMARY CNS NEOPLASMS
【2h】

GENE-39. UNANTICIPATED GERMLINE CANCER SUSCEPTIBILITY MUTATIONS IDENTIFIED DURING ROUTINE NEXT GENERATION SEQUENCING OF PRIMARY CNS NEOPLASMS

机译:基因39。原发性中枢神经系统坏死的例行常规次世代测序中鉴定出的未预料的子宫颈癌敏感性突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

INTRODUCTIONTumor genomic profiling is routinely performed on primary brain tumors to identify somatic mutations. Such testing may also identify clinically significant germline mutations. Several syndromes (neurofibromatosis, Li Fraumeni, Von Hippel Lindau and Turcot) are well known causes of primary CNS neoplasms but there is limited data on other germline cancer susceptibility mutations in CNS tumor patients. After a somatic mutation was unexpectedly found to be germline, we interrogated our database of somatic CNS tumor mutations.
机译:引言常规在原发性脑肿瘤上进行肿瘤基因组谱分析以鉴定体细胞突变。这样的测试还可以鉴定临床上显着的种系突变。几种综合征(神经纤维瘤病,李Fraumeni,Von Hippel Lindau和Turcot)是原发性中枢神经系统肿瘤的众所周知原因,但有关中枢神经系统肿瘤患者中其他种系癌症易感性突变的数据有限。在意外地发现体细胞突变是种系之后,我们询问了我们的体细胞中枢神经系统肿瘤突变数据库。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号